TABLE 2.
Association between estrogens and estrogen metabolites with fecal microbial alpha diversity (N = 110)a
Estrogens and estrogen metabolites | Mutually adjusted modelb |
Individual hormone modelc |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Observed ASVs |
Faith's PD |
Shannon index |
Observed ASVs |
Faith's PD |
Shannon index |
|||||||
(global p-value = 0.07) |
(global p-value = 0.22) |
(global p-value < 0.01) |
||||||||||
β | P value | β | P value | β | P value | β | P value | β | P value | β | P value | |
Parent Estrogens | ||||||||||||
Estrone | 14.14 | 0.15 | 0.70 | 0.25 | 0.36 | 0.03 | 10.17 | 0.05 | 0.65 | 0.04 | 0.22 | 0.02 |
Unconjugated Estrone | — | — | — | — | — | — | 6.33 | 0.40 | 0.39 | 0.39 | 0.19 | 0.15 |
Conjugated Estrone | — | — | — | — | — | — | 10.31 | 0.02 | 0.67 | 0.01 | 0.20 | 0.01 |
Estradiol | 1.72 | 0.86 | −0.05 | 0.94 | 0.15 | 0.35 | 10.42 | 0.05 | 0.63 | 0.05 | 0.25 | 0.01 |
Unconjugated Estradiol | — | — | — | — | — | — | 6.08 | 0.28 | 0.41 | 0.24 | 0.16 | 0.10 |
Conjugated Estradiol | — | — | — | — | — | — | 5.21 | 0.05 | 0.31 | 0.05 | 0.11 | 0.02 |
2-Hydroxylation Pathway Metabolites | ||||||||||||
2-Hydroxyestrone | −3.42 | 0.84 | 0.42 | 0.70 | −0.49 | 0.10 | 17.52 | 0.07 | 1.23 | 0.03 | 0.30 | 0.08 |
2-Hydroxyestradiol | 11.76 | 0.13 | 0.51 | 0.29 | 0.30 | 0.02 | 6.39 | 0.38 | 0.34 | 0.43 | 0.19 | 0.13 |
2-Hydroxyestrone-3-methyl ether | 1.35 | 0.90 | −0.11 | 0.86 | −0.05 | 0.77 | 10.78 | 0.14 | 0.46 | 0.30 | 0.14 | 0.27 |
2-Methoxyestrone | −1.28 | 0.90 | −0.12 | 0.84 | 0.15 | 0.35 | 6.67 | 0.33 | 0.43 | 0.30 | 0.19 | 0.11 |
Unconjugated 2-Methoxyestrone | — | — | — | — | — | — | 0.28 | 0.97 | 0.06 | 0.87 | 0.07 | 0.55 |
Conjugated 2-Methoxyestrone | — | — | — | — | — | — | 1.55 | 0.68 | 0.13 | 0.57 | 0.06 | 0.34 |
2-Methoxyestradiol | -7.52 | 0.47 | -0.27 | 0.68 | -0.11 | 0.52 | −6.49 | 0.42 | −0.26 | 0.58 | −0.07 | 0.64 |
Unconjugated 2-Methoxyestradiol | — | — | — | — | — | — | −2.83 | 0.75 | −0.27 | 0.62 | 0.01 | 0.95 |
Conjugated 2-Methoxyestradiol | — | — | to | — | — | — | −5.75 | 0.31 | −0.24 | 0.48 | −0.06 | 0.56 |
4-Hydroxylation Pathway Metabolites | ||||||||||||
4-Hydroxyestrone | −5.58 | 0.59 | −0.26 | 0.69 | −0.24 | 0.17 | 9.62 | 0.13 | 0.50 | 0.19 | 0.16 | 0.15 |
4-Methoxyestrone | 16.07 | 0.15 | 0.67 | 0.33 | 0.51 | 0.01 | 17.99 | 0.02 | 0.89 | 0.06 | 0.42 | <0.01* |
4-Methoxyestradiol | 0.67 | 0.95 | −0.30 | 0.66 | 0.14 | 0.45 | −8.07 | 0.35 | −0.74 | 0.16 | −0.09 | 0.55 |
16-alpha-Hydroxylation Pathway Metabolites | ||||||||||||
Estriol | 14.70 | 0.16 | 0.94 | 0.15 | 0.36 | 0.04 | 12.69 | 0.05 | 0.81 | 0.04 | 0.25 | 0.03 |
Unconjugated Estriol | — | — | — | — | — | — | −4.49 | 0.65 | −0.28 | 0.64 | 0.08 | 0.65 |
Conjugated Estriol | — | — | — | — | — | — | 10.81 | 0.04 | 0.69 | 0.03 | 0.21 | 0.02 |
16-alpha-Hydroxyestrone | −23.19 | 0.02 | −0.99 | 0.10 | −0.57 | <0.01 | −1.59 | 0.76 | −0.01 | 0.97 | −0.01 | 0.91 |
16-Ketoestradiol | 8.26 | 0.44 | 0.13 | 0.85 | 0.19 | 0.28 | 5.89 | 0.36 | 0.28 | 0.47 | 0.11 | 0.35 |
16-Epiestriol | −4.55 | 0.60 | −0.29 | 0.58 | −0.09 | 0.53 | 7.15 | 0.24 | 0.37 | 0.31 | 0.13 | 0.25 |
17-Epiestriol | 15.53 | 0.09 | 0.98 | 0.09 | 0.15 | 0.33 | 18.46 | 0.01 | 0.96 | 0.02 | 0.28 | 0.03 |
Linear regression model that includes all metabolites with additional adjustment for age and BMI; the missing BMI value of one woman was replaced by the median category; ASVs, amplicon sequence variants; Faith's PD, Faith’s phylogenetic diversity.
As the concentration of the 5 conjugated metabolites are calculated as the difference between the combined estrogen measurement and the unconjugated estrogen measurement (e.g., conjugated estrone = estrone − unconjugated estrone), the unconjugated and conjugated analytes were not included in the mutually adjusted model.
The False discovery rate (FDR) adjusted P value was calculated for the individual hormone models to adjust for multiple testing; *FDR adjusted P value ≤0.05; The P values present in the table are all normal P values.